论文部分内容阅读
目的:观察清肺豁痰汤治疗小儿咳嗽痰热壅肺证的临床疗效。方法:选择我院于2013年11月至2015年2月期间收治的痰热壅肺患儿52例作为研究对象,随机分为对照组和观察组,各26例。观察组患儿给予清肺豁痰汤口服治疗,3天为1个疗程,连续治疗3个疗程;对照组患儿给予炎琥宁+利巴韦林治疗,比较两组患儿治疗效果、痊愈时间及不良反应情况等。结果:经过3个疗程治疗后,观察组患儿总有效率为92.31%,对照组为57.69%,观察组临床疗效显著高于对照组。两组患儿治愈时间比较:观察组患儿平均(9.35±3.24)天,对照组患儿平均(14.45±2.24)天;观察组患儿治愈时间显著短于对照组,组间差异P<0.05;观察组患儿住院时间平均(10.65±2.97)天,对照组患儿平均(13.26±3.67)天;观察组患儿住院时间显著短于对照组,组间差异P<0.05。不良反应及并发症情况统计:观察组患儿不良反应发生率为3.85%(1/26),对照组患儿不良反应发生率为26.92%(7/26),观察组不良反应发生率显著低于对照组,组间差异P<0.05;并发症情况:观察组患儿均未出现并发症,对照组并发症发生率为3.85%(1/26),观察组并发症发生率与对照组比较,组间差异不显著P>0.05。结论:清肺豁痰汤治疗小儿咳嗽痰热壅肺证临床疗效优于单纯西药治疗,患儿临床症状改善较快,预后良好,应推荐清肺豁痰汤治疗方法。
Objective: To observe the clinical efficacy of Qingfeihuatan decoction in treating children with cough, phlegm and heat lungs. Methods: Fifty-two children with phlegm-heat syndrome admitted to our hospital from November 2013 to February 2015 were randomly divided into control group and observation group, with 26 cases in each group. Children in the observation group were treated with Qingfeihuotan Decoction orally, three days for a course of treatment for three courses of continuous treatment; control group of children given Yanhuning + ribavirin treatment, the treatment effect of two groups were compared and healed Time and adverse reactions and so on. Results: After 3 courses of treatment, the total effective rate of the observation group was 92.31% and that of the control group was 57.69%. The clinical efficacy of the observation group was significantly higher than that of the control group. The average healing time was 9.35 ± 3.24 days in the observation group and 14.45 ± 2.24 days in the control group. The cure time in the observation group was significantly shorter than that in the control group, P <0.05 (10.65 ± 2.97) days in the observation group and 13.26 ± 3.67 days in the control group. The hospitalization time in the observation group was significantly shorter than that in the control group, with a significant difference between the groups (P <0.05). Adverse reactions and complications Statistics: The incidence of adverse reactions in the observation group was 3.85% (1/26), the incidence of adverse reactions in the control group was 26.92% (7/26), and the incidence of adverse reactions in the observation group was significantly lower In the control group, the differences between groups were significant (P <0.05). Complications: No complications occurred in the observation group, and the incidence of complications in the control group was 3.85% (1/26). The complication rate in the observation group was significantly higher than that in the control group , No significant difference between groups P> 0.05. Conclusion: Qingfei Huotan Decoction in children with cough, phlegm and heat lung disease clinical efficacy is better than Western medicine alone, children with clinical symptoms improved rapidly, the prognosis is good, should be recommended Qingfei Huotan Decoction treatment.